Gastrointestinal tract
Colorectal adenocarcinoma
The model of stepwise carcinogenesis: a benign adenoma collects mutations (APC, KRAS, SMAD4, TP53, mismatch repair) over years and becomes an invasive adenocarcinoma.
Causes et facteurs de risque
- Adenomas, the benign precursors: found in half of adults over 50; risk rises with size over 2 cm and with villous architecture
- Familial adenomatous polyposis (APC): over 100 adenomas by adolescence; nearly all develop cancer without colectomy
- Hereditary non-polyposis colon cancer (Lynch syndrome): mismatch repair gene mutations, right-sided cancers in young people
- Long-standing ulcerative colitis
- A diet low in fibre and high in refined foods and fat
Aspect macroscopique
- Tubular adenoma: a small, smooth, often pedunculated polyp. Villous adenoma: a broad, sessile, cauliflower-like mass of several centimetres.
- Carcinoma: an exophytic mass or an encircling “napkin-ring” lesion that narrows the lumen, often with a bleeding ulcerated centre.
Au microscope
- Adenoma: crowded glands with dysplastic, hyperchromatic nuclei and fewer goblet cells, without invasion of the stalk.
- About 40% of villous adenomas harbour invasive carcinoma.
Évolution
- Loss of APC lets β-catenin accumulate and drive cell proliferation: an adenoma forms.
- Over years the adenoma grows and gathers mutations in KRAS, SMAD4 and TP53, or develops microsatellite instability.
- Dysplastic epithelium invades through the muscularis mucosae: adenocarcinoma.
- The tumour bleeds, obstructs and spreads, for example to the liver.
Complications
- Occult blood in the stool, and iron deficiency anaemia
- Change in bowel habit and partial obstruction
- Metastasis, notably to the liver
- Villous adenomas can lose potassium and protein
Examens complémentaires
- Colonoscopy with biopsy
- Shows the tumour and any other polyps; histology confirms adenocarcinoma.
- Faecal immunochemical test (FIT)
- Detects hidden blood; used in screening.
- CT of chest, abdomen and pelvis
- Stages the tumour, including liver and lung metastases; MRI stages rectal cancers.
- Carcinoembryonic antigen (CEA)
- A baseline before treatment and for follow-up; not a diagnostic test.
- Full blood count
- Iron-deficiency anaemia, particularly with right-sided cancers.
Traitement médicamenteux
- Haematinics: iron, folic acid and vitamin B12: The building blocks red cells need: iron for haemoglobin, folic acid and vitamin B12 for DNA synthesis in dividing marrow cells. Each corrects only its own deficiency.
- Fluoropyrimidines (5-fluorouracil, capecitabine): Antimetabolites that starve dividing cells of thymidine for DNA; the backbone of chemotherapy for colorectal cancer, including cancer that has spread to the liver.
- Platinum compounds (cisplatin, carboplatin, oxaliplatin): Cytotoxic drugs that cross-link DNA; the backbone of chemotherapy for lung, testicular, gastric and colorectal cancers and osteosarcoma. Each has its own toxicity: cisplatin the kidney and ear, carboplatin the marrow, oxaliplatin the nerves.
- Topoisomerase inhibitors (etoposide, irinotecan): Drugs that trap DNA-cutting enzymes on DNA: etoposide (topoisomerase II) in testicular tumours and small cell lung cancer; irinotecan (topoisomerase I) in colorectal cancer.
Anatomie concernée
Sujets liés
Rédigé d’après
- Robbins and Cotran Atlas of Pathology, 3rd ed., Ch. 7, The Gastrointestinal Tract, pp. 213–216, figs 7-114 to 7-126
Ressource pédagogique. Ne constitue pas un avis, un diagnostic ou un traitement médical.